<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05109962</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0452</org_study_id>
    <nct_id>NCT05109962</nct_id>
  </id_info>
  <brief_title>Management of Robertsonian Translocation PGT-SR Attempts</brief_title>
  <official_title>New Recommendations for Robertsonian Translocation Management After Preimplantation Genetic Testing of Structural Rearrangement (PGT-SR) Attempts: What Should be Done With Mosaic Embryos?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      to analyze if a probe strategy choice for PGT-SR studies of Robertsonian translocations (RT)&#xD;
      influences the fate of embryos? Few studies discussed the importance of probe choices.&#xD;
      However, those who did, demonstrated that analysis with locus specific probes improve a&#xD;
      diagnosis of dubious results, and addition of a centromeric probe could affect the accuracy&#xD;
      of diagnosis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2006</start_date>
  <completion_date type="Actual">December 1, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants with detect all chromosome segments</measure>
    <time_frame>1 day</time_frame>
    <description>Number of Participants with detect all chromosome segments</description>
  </primary_outcome>
  <enrollment type="Actual">148</enrollment>
  <condition>Robertsonian Translocation</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      NC&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Robertsonian translocation carriers are phenotypically normal, but they are known to be at&#xD;
        increased risk of repeated miscarriages compared with the general population estimated at&#xD;
        about 15% of pregnancies, and also resulting in the birth of a child with congenital&#xD;
        anomalies or a mental retardation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Adult patient whom carrying robertsonian translocations in the context of PGT-SR&#xD;
             management&#xD;
&#xD;
          -  age &gt; 18 years&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - age &lt; 18 years&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reda Zenagui, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 5, 2021</study_first_submitted>
  <study_first_submitted_qc>October 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Several years of miscarriages</keyword>
  <keyword>Abortions and primary infertility</keyword>
  <keyword>FISH with 2 probes</keyword>
  <keyword>FISH with 3 probes</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

